TY - JOUR
T1 - The impact of COVID-19 on managing ophthalmic diseases
T2 - an international, descriptive study
AU - Waisberg, Ethan
AU - Ong, Joshua
AU - Zaman, Nasif
AU - Kamran, Sharif Amit
AU - Tavakkoli, Alireza
AU - Lee, Andrew G.
N1 - © 2023. The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. Aims: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. Methods: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. Results: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. Conclusions: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19.
AB - Background: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. Aims: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. Methods: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. Results: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. Conclusions: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19.
KW - COVID-19
KW - Ophthalmic disease
KW - Ophthalmology
KW - Ophthalmologists
KW - Eye Diseases/epidemiology
KW - Humans
KW - Surveys and Questionnaires
KW - Communicable Disease Control
KW - Pandemics/prevention & control
UR - http://www.scopus.com/inward/record.url?scp=85147750597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147750597&partnerID=8YFLogxK
U2 - 10.1007/s11845-023-03306-9
DO - 10.1007/s11845-023-03306-9
M3 - Article
C2 - 36773204
AN - SCOPUS:85147750597
SN - 0021-1265
VL - 192
SP - 3101
EP - 3103
JO - Irish Journal of Medical Science
JF - Irish Journal of Medical Science
IS - 6
ER -